Summary: To study MPTP-induced muscular rigidity, we try to detect the changes of both dopamine (DA) and GABA within rat striatums by immunohistochemical means. A high dose (30 mg/kg) of MPTP i.p. injected into rats produces behavioral abnormalities (tremor and ataxia), and higher doses (>60 mg/kg) develop an acutely muscular rigidity without producing a measurable histological change. GABA is induced in the striatum of 4 MPTP (30 mg/kg) i.p. treated-rats developed tremor and ataxia. But the animals recovered to an apparently normal state and are not showed GABAimmunoreactivity.
In some previous reports4'6 '7) , it was noted that MPTP, the DAergic neurotoxin, had a marked, if temporary, effect on locomotor activity in rats without producing measurable histological changes at the microscopic level. This acute neurological syndrome, which consisted of tremor, rigidity and hypertonus, is sometimes called serotonin syndrome, because of the resemblance to those conditions occuring after a single administration of serotonin agonists4 '6) . However, Steranka L. R. et a1.8, using high pressure liquid chromatography with electrochemical detection reported, that MPTP lead to a reduction in both striatal DA and serotonin concentrations. It was suggested that neuronal abnormalities were a closely related phenomenon within the striatum3). Changes in neuronal activity within the striatum are at least partly funneled out of this nucleus via two GABAergic projections to the main output stations of basal ganglia, the pallidum and the substantia nigra (S.N.)2). So the DAergic and GABAergic mechanisms might be involved in the development of behavioral abnormalities in MPTP-treated rats. In the present investigation, we used immunohistochemical method to analyze how DA and GABA interact within the striatum and how neuronal information from the S.N. pars compacta is functionally processed within the striatum with respect to the development of muscular rigidity by intraperitoneal injection of MPTP. In addition, we tried to detect serotonin induction via immunohistochemical means to study whether or not the associated behavioral abnormality is caused by serotonin syndrome.
Materials and Methods
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Wistar strain rats (7 weeks old, body weight 150-170 g) were used for a study involving administration of MPTP. A single intraperitoneal (i.p.) injection at doses of 10, 30, 60 and 90 mg/kg of MPTP dissolved in distilled water was administrated to 37 rats. MPTP (30 mg/kg) i.p. injection was given daily for 4 days to 14 rats. A single i.p. injection of distilled water alone was administrated to 4 rats. For investigation of acute effects of intoxication, the rats were perfused through the left ventricle 271 with periodate-lysine-paraformaldehyde solution (0.01 M NaI04-0.075 M phosphate buffer-4% paraformaldehyde, pH 6.2) under deep sodium-pentobarbital anethesia after 15 minutes of MPTP i.p. injection. To investigate of changes of the brain in recovering from behavioral abnormalities, some of the 4 MPTP (30 mg/kg)-treated animals were sacrificed after 24 hours of the last injection. Brains were removed and placed in a fresh perfusate at 4°C for 1 hour. Two kinds of blocks, one containing the S.N. (2 mm in thickness) and the other containing the striatum (2 mm in thickness) were dissected from the brain, dehydrated, and embedded in soft paraffin. Serial sections (4 [tm) were made. These were dried (50°C), deparaffinized in xylene and rinsed in ethanol (100%). Five serial sections were processed with Nissl stain for cytoarchitecture and immunohistochemical analysis of DA, TH (tyrosine hydroxylase), serotonin and GABA. Both the S.N. and the striatum of distilled water injected-rats were checked and used as controls.
The immunohistochemical procedure (the streptavidine-peroxidase conjugate (SP) method, Nichirei Corporation), in which peroxidase was used as the enzyme, was performed as follows. After deparaffinization, endogenous peroxidase was blocked by 3% H202 for 15 minutes. After washing with PBS, the tissue sections were treated with 10% normal goat serum for 10 minutes. Next, the sections were soaked immersed at room temperature for 4 hours in the primary antibodies against (DA, TH and serotonin). The primary antibody to GABA reacted for 24 hours at 4°C. The primary antibody of DA was rabbit-antiserum (Cosmo Bio Co) diluted at a ratio of 1:50 in PBS. The primary antibody of TH was rabbit-antiserum (Chemicon) diluted at a ratio of 1:100 in PBS. The primary antibody of serotonin was rabbit-antiserum (INCSTER) diluted at a ratio of 1:100 in PBS. The primary antibody of GABA was rabbit-antiserum (Cosmo Bio Co) diluted to 1:50 in PBS. After washing with PBS, the tissue sections were exposed to a biotinylated goat antirabbit IgG for 10 minutes. And then each antibody was conjugated with horseradish peroxidase, utilizing the streptavidine-biotin method (Nichirei Corporation) for 5 minutes at room temperature. Diaminobenzidine (DAB) was used as the chromogen.
For the study of cytoarchitecture, Nissl stain was used to identify the S.N.* and the striatum**.
Results
Clinical Effects
The clinical effects in rats are shown in Table I . The low dose (10 mg/kg) i.p. injection appeared to have little effect, while a higher dose (30 mg/kg) i.p. produced an acute neurological syndrome which consisted of ataxia, limb weakness and tremor. This acute syndrome completely disappeared on the following day. Out of the 14 rats injected daily with (30 mg/kg) i.p. for 4 days, 2 died and 2 became feeble 24 hours after the last MPTP injection. The dose of 60 mg/kg invariably caused seizures and muscular rigidity. But in this case, 6 rats died immediately after repeated generalized seizures. A dose of 90 mg/kg invariably caused seizures and muscular rigidity and were proven to be uniformly fatal shortly.
Immunohistochemical observations
The objective of this study was to examine the immunohistochemical effects of DA, serotonin and GABA in consecutive coronal sections of both the striatum and the S.N. after MPTP i.p. injection. In addition, TH-immunoreactivity was visualized in adjacent sections as a marker of DA levels in striatal neurons°. It was clearly demonstrated that positive reactivity to each antiserum occurred in the tissue. Positive reactions to DA, TH, serotonin and GABA Table 1 .
Clinical effects of MPTP intraperitoneal administration in rats
The S.N.* and the striatum** Abbreviations in this paper are mostly taken from the atlas of Paxinos and Watson.
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were proven in both the striatum and the S.N. by the presence of the reddish-brown precipitates of oxidized DAB.
1-1 Control Substantia Nigra
Cathecholaminergic neurons in the S.N. in the distilled water-injected rats were of normal size, shape and packing density in Nissl stain. Mediumsized basophilic neurons (20-45 min) of the S.N. pars compacta were situated at the dorso-medial side of the S.N. throughout the anterior-posterior extent (Fig. 1) . Neurons of the S.N. pars reticularis located within the more anterior and ventro-lateral segments of the S.N. were slightly smaller in diameter (12-26 rim)than those of the S.N. pars compacta. The DA-immunoreactivity of control tissues was observed in many of the medium-sized neurons of the S.N. pars compacta and occasionally in those of the S.N. pars reticularis (Fig. 2) . Most of the S.N. pars compacta nerve cells and occasionally those of the S.N. pars reticularis showed dense TH-immunoreactivity (Fig. 3) . Innumerable dots and fiberlike structures were observed in the neuropile of the S.N. pars compacta and partly in the S.N. pars reticularis (Fig. 3) . Weak serotonin-immunoreactivity of the control tissues was observed in many of the medium-sized neurons of the S.N. pars compacta and occasionally in neurons of the S.N. pars reticularis (Fig. 4) . GABA-immunoreactivity of control tissues was also observed in the vast majority of the medium-sized neurons of the S.N. pars compacta and occasionally in neurons of the S.N. pars reticularis (Fig. 5 ).
1-2 MPTP-treated Substantia Nigra
Experimental brains from the rats treated with a single i.p. injection of either 10 mg/kg-or 30 mg/kg did not show any immunohistochemical changes in comparison with the controls. The 6 brains of the rats that received 4 MPTP (30 mg/kg) i.p. developed tremor and ataxia, and were sacrificed 15 minutes after the last injection did not show any immunohistochemical changes related to the DA, TH, serotonin and GABA. The 6 animals received 4 MPTP (30 mg/kg) i.p. , recovered to an apparently normal state, and survived 24 hours after the last injection. Their brain did not also show any immunohistochemical changes in the DA, TH, serotonin and GABA contents. The 11 animals which were injected with 60 mg/kg developed muscular rigidity, and were sacrificed 15 minutes after MPTP administration. Their brains showed fine fiber-like positivestructures (not very clear stained) in the dorso-medial half of the neuropile of the S.N. pars compacta and the adjacent dorso-medial neuropile throughout the anterior-posterior extent (Fig. 8) . Many of the THimmunoreactive cells of the S.N. of the animals which received 60 mg/kg of MPTP i.p., showed higher stainability than those of the controls (Fig. 8) . The stainability of the DA-and serotonin-positive neurons of the rats that received 60 mg/kg of MPTP was generally comparable to that of the control neurons (Figs. 7 and 9) . But both the DA-and serotonin-positive cells were reduced in number in comparison with the controls. The stainability of the GABA-positive neurons of the rats which received 60 mg/kg of MPTP was higher than that of the controls (Fig. 10) . In observing 5 serial sections, the outstanding histological change in these brains was neovascularization at the ventro-lateral half of the neuropile of the S.N. pars compacta and adjacent ventro-lateral area (Figs. 6, 7, 8, 9 and 10 ). However the medium-sized (cathecholaminergic) neurons looked almost identical with the controls in Nissl stain sections (Fig. 6 ).
II-1 Control Striatum
From observations of the Nissl stain sections, the vast majority of nerve cells in the striatum were medium-sized (10-20 tim) spiny neurons (Fig. 12) . DA-immunoreactive structures in the distilled water injected striatum were visualized in the nuclei of the medium-sized spiny neurons. TH-immunoreactive fibers were identified in the ascending cathecholaminergic pathway') and immunoreactive axons and terminals were seen in the striatum (Fig. 16) . But due to the density of TH-immunostained axons and terminals, individual axons could not be discerned. In comparison with two serial sections , the TH-immunoreactive neuropiles of the control striatum showed many negative patches as if they were DA island ( Fig. 16; . Weak serotonin-immunoreactivity was observed in many nuclei of medium-sized spiny neurons (Fig. 18) . Faint GABA-immunoreactivity was observed in many cell bodies of medium-sized spiny neurons (Fig. 20) .
II-2MPTP-treated Striatum
Experimental brains from the rats which received a single injection of either 10 mg/kg-or 30 mg/kg did not show any immunohistochemical changes compared with the controls. Six rats which received 4 MPTP (30 mg/kg) i.p. developed tremor and ataxia , and were sacrificed 15 minutes after the last injection . Their brains showed weak GABA-immunoreactivitv in the medium-sized spiny neurons . Their immunoreactions to DA, TH and serotonin were almost identical to those of the control. However 6 animals which received 4 MPTP (30 mg/kg) i.p . , recovered to an apparently normal state and survived 24 hours after the last injection. Their brains did not show any immunohistochemical changes in the DA , TH, serotonin and GABA. 11 rats which were injected with 60 mg/kg developed muscular rigidity, and were sacrificed 15 minutes after MPTP administration. Their brain showed a slight reduction in the stainability of the DA-positive neurons (Fig. 13) . The immunoreactions to both TH and serotonin were almost identical to those of the control (Figs .  15 and 17) . The prominent immunohistochemical change of these 60 mg/kg-treated brains was dense immunoreactivity of GABA in the medium-sized spiny neurons (Fig. 19) . But the striatal neurons looked almost identical with the controls in the Nissl stained sections (Fig. 11) . Discussion MPTP i.p. injection at a high dosage (30 mg/kg) in rats has been known to produce behavioral abnormalities6M (Table 1 ) and higher dosages (>60 mg/ kg) develop acute muscular rigidity (Table 1) without producing measurable histological changel'4'8) (Fig.  11) . In addition, the results of the present study show that the striatum which has been treated with 4 MPTP (30 mg/kg) i.p. developed tremor and ataxia: GABA was induced in this striatum while GABAinduction was not detected after 24 hours. Furthermore we found dense GABA-immunoreactivity in the striatum which was responsible for the development muscular rigidity, when the rats were injected with 60 mg/kg MPTP i.p. (Fig. 19) . The vast majority of GABA-positive cells in our observation were medium-sized spiny neurons (Fig. 19) . Some of the medium-sized spiny neurons which projected to the S.N. give off extensive local collaterals within the striatum. Ellenbroek B. et al.2) described that the activity of medium-sized striato-nigral spiny neurons is regulated by GABA which is released from the axon-collaterals and interneurons. The induction of GABA suggests an increase of neuronal activity within the MPTP-treated striatum of our study. An electromyographic (EMG) study in rats has substantiated the importance of GABAergic transmission in the striatum in the development of muscular rigidity2).
The current study indicates that 4 MPTP (30 mg/ kg) i.p. injection dose not cause any changes in DAimmunoreactivity. Willoughby J. et al.9) reported that rats were much less sensitive to MPTP and at high doses and showed only some reversible depletion of DA in the striatum. Steranka L. R. et al. 8) reported that MPTP given by bolus injection followed by osmotic minipump infusion for 24 hours into rats lead to a reduction in the striatal DA concentration one week later. Other workers have demonstrated that little change in striatal DA levels occurs after MPTP administration in rats4'7). These differences may reflect the effects of routes of administration and time of sacrifice after MPTP administration. Through haloperidol-induced tonic EMG activity, it has been found that attenuation of DAergic activity within the striatum results in muscular rigidity3). In other words, muscular rigidity may be relevant to both slight depletion of DA-immunoreactivity and the induction of GABA-immunoreactivity within the rat striatum which receive MPTP via i.p. injection in our study. The results of this study present some insight as to how DA and GABA function within the striatum with respect to the development of neuronal abnormality.
By observing of anti-TH stained sections of MPTPtreated S.N., it was found that the animals which received 60 mg/kg MPTP i.p. developed muscular rigidity, show not very clear stain (fine fiber-like structures) in the dorso-medial half of neuropile of the S.N. pars compacta and adjacent dorso-medial neuropile throughout its anterior-posterior extent (Fig. 8) . This fine fiber-like structures may suggest that TH is induced within the peripheral fine axons of the dorso-medial half of the S.N. pars cornpacta and adjacent dorso-medial area, where TH is normally absent, due to the treatment with 60 mg/kg MPTP i.p.. And TH-induction within the peripheral fine axons may be required for cathechol amine for mation.
The striato-nigral GABAergic projection gets feedback inhibition of the nigrostriatal DAergic pathway which arises in the S.N. pars compacta and it functions as a feedforward system on non-DAergic nigral efferents which originate in the S.N. pars reticularis and connect the striatum with thalamus, superior colliculus and reticular fot mation2'3). Our behavioral and immunohistochemical studies suggest that the effects induced by the depletion of DA within the striatum may be mediated through the inhibition of the striato-nigral GABAergic pathway which in turn may lead to an activation of the nigrothalamic or nigro-collicular GABAergic pathway2) Some authors believe that behavioral abnormali.
ties of the MPTP-treated rats represent a serotonin syndrome4 '6) .
The present study can not detect an increase in serotonin-immunoreactivity in either the striatum or the S.N.. In addition, the number of serotonin-immunoreactive cells in the MPTPtreated S.N. shows a slight decrease in comparison with the control. Though MPTP-induced neuronal abnormalities in rats may involve multiple neurotransmitter systems, the present study demonstrates principal abnormalities in both the DA-and the GABA-systems but not the serotonin-system within the striatum.
In the view of immunohistochemistry, the induction of GABA-immunoreactivity might be more a remarkable change that the depletion of DA-immunoreactivity.
In conclusion, the present study points to the significant role that the striatal GABAergic transmission plays in the development of muscular rigidity. The activity within the striatum can be traced by immunohistochemical technique for GABA morphologically. The detection of GABA seems to be reliable index of muscular rigidity. and E. Kawana Five serial sections for Nissl stain (Fig. 1) , DA (Fig. 2) , TH (Fig. 3) , serotonin (Fig. 4) and GABA (Fig. 5 ) in the brain of the normal adult rat. Many of medium-sized neurons of the S.N. are positive for DA (Fig. 2 arrows) . TH-immunoreactivity is seen in the majority of medium-sized neurons (Fig. 3 arrow 1) . And innumerable dots ( Fig. 3 arrow 2) and fiber-like structures (Fig.  3 arrow 3) are seen in the neuropile of the S.N. pars compacta and partly the S.N. pars reticularis. In the normal S.N., weak scrotonin-immunoreactivity is observed in many of medium-sized neurons (Fig. 4 arrows) . GABA-immunoreactivity is also observed in the vast majority of medium-sized neurons (Fig. 4 arrows) . The asterisk shows the same capillary. And these pictures (Figs. 1, 2, 3, 4 and 5) show the S.N. on the right side. C: the S.N. pars compacta. R: the S.N. pars reticularis. Bar: 100 iim.
